Clinical Research Site #300

Calgary, Alberta T2R 0X7

1 studies enrolling now · 1 studies all time

What they study most

Immunoglobulin A Nephropathy

Studies at this site

• Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) — Enrolling by invitation